A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).

A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).

Show other versions (1)

书目详细资料
Main Authors:	Bradbury, P, Lang, B, Vincent, A, Han, C, Talbot, D
格式:	Conference item
出版:	2004

相似书籍

A prospective study of the incidence of sub-clinical Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer (SCLC)
由: Bradbury, P, et al.
出版: (2004)

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
由: Payne, M, et al.
出版: (2010)

Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
由: Lang, B
出版: (2007)

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
由: Lang, B, et al.
出版: (2013)

Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
由: Lang, B, et al.
出版: (2003)

Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma
由: Lang, B, et al.
出版: (2008)

Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
由: Titulaer, M, et al.
出版: (2011)

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
由: Maddison, P, et al.
出版: (2001)

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome
由: Titulaer, M, et al.
出版: (2010)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
由: Palace, J, et al.
出版: (2004)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
由: Lorenzoni, P, et al.
出版: (2008)

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
由: Titulaer, M, et al.
出版: (2011)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
由: Squier, M, et al.
出版: (1991)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
由: Maddison, P, et al.
出版: (2011)

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
由: Wirtz, P, et al.
出版: (2005)

Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
由: Lehnerer, S, et al.
出版: (2024)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report
由: Cruz, M, et al.
出版: (2005)

Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
由: Simister, R, et al.
出版: (2011)

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
由: Bain, P, et al.
出版: (1996)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
由: Motomura, M, et al.
出版: (1997)

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
由: Wirtz, P, et al.
出版: (2003)

P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
由: Wirtz, P, et al.
出版: (2005)

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
由: Pinto, A, et al.
出版: (2002)

Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
由: Rozsa, C, et al.
出版: (2008)

Spontaneously resolving paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome in association with treatment-sensitive Lambert-Eaton myasthenic syndrome
由: Simister, R, et al.
出版: (2006)

Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
由: Vincent, A
出版: (2008)

Synaptotagmin 2 Mutations Cause an Autosomal-Dominant Form of Lambert-Eaton Myasthenic Syndrome and Nonprogressive Motor Neuropathy
由: Herrmann, David N., et al.
出版: (2017)

Clinical characteristics of Lambert-Eaton myasthenic syndrome with positive P/Q-type voltage-gated calcium channel antibody
由: Tan, Y, et al.
出版: (2021)

The isolation and characterisation of the genes coding for the calcium channel affected by Lambert-Eaton myasthenic syndrome antibodies in NG108-15 cells
由: von Rosch, A
出版: (1992)

Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
由: Spillane, J, et al.
出版: (2015)

Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome
由: Tschernatsch, M, et al.
出版: (2009)

Congenital myasthenic syndromes.
由: Beeson, D, et al.
出版: (1997)

Myasthenia gravis and myasthenic syndromes
由: Vincent, A
出版: (2007)

DETECTION OF SMALL CELL LUNG-CARCINOMA (SCLC) CELLS IN BONE-MARROW USING MONOCLONAL-ANTIBODIES (MOABS)
由: Moss, F, et al.
出版: (1988)

LEM IPT
由: Nightingale, Debbie, et al.
出版: (2013)

LEM IPT
由: Shields, Tom, et al.
出版: (2013)

The congenital myasthenic syndromes.
由: Palace, J, et al.
出版: (2008)

Therapy of myasthenic syndrome
由: Palace, J
出版: (2012)

Congenital myasthenic syndromes: an update.
由: Finlayson, S, et al.
出版: (2013)

SOX1 autoantibodies: tumor markers in LEMS patients?
由: Lang, B, et al.
出版: (2008)